Vor Capex To Operating Cash Flow from 2010 to 2025

VOR Stock  USD 0.88  0.07  7.64%   
Vor Biopharma Capex To Operating Cash Flow yearly trend continues to be relatively stable with very little volatility. Capex To Operating Cash Flow is likely to drop to -0.01. During the period from 2010 to 2025, Vor Biopharma Capex To Operating Cash Flow destribution of quarterly values had range of 0.1051 from its regression line and mean deviation of  0.02. View All Fundamentals
 
Capex To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
(0.01)
Current Value
(0.01)
Quarterly Volatility
0.03046745
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vor Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vor Biopharma's main balance sheet or income statement drivers, such as Net Interest Income of 8.6 M, Interest Income of 8.6 M or Depreciation And Amortization of 3.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. Vor financial statements analysis is a perfect complement when working with Vor Biopharma Valuation or Volatility modules.
  
Check out the analysis of Vor Biopharma Correlation against competitors.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

Latest Vor Biopharma's Capex To Operating Cash Flow Growth Pattern

Below is the plot of the Capex To Operating Cash Flow of Vor Biopharma over the last few years. It is Vor Biopharma's Capex To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vor Biopharma's overall financial position and show how it may be relating to other accounts over time.
Capex To Operating Cash Flow10 Years Trend
Slightly volatile
   Capex To Operating Cash Flow   
       Timeline  

Vor Capex To Operating Cash Flow Regression Statistics

Arithmetic Mean(0.07)
Geometric Mean0.05
Coefficient Of Variation(46.00)
Mean Deviation0.02
Median(0.08)
Standard Deviation0.03
Sample Variance0.0009
Range0.1051
R-Value0.53
Mean Square Error0.0007
R-Squared0.28
Significance0.04
Slope0
Total Sum of Squares0.01

Vor Capex To Operating Cash Flow History

2025 -0.0101
2024 -0.009593
2023 -0.0107
2022 -0.0994
2021 -0.0563
2020 -0.11

About Vor Biopharma Financial Statements

Vor Biopharma shareholders use historical fundamental indicators, such as Capex To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Vor Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Vor Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vor Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capex To Operating Cash Flow(0.01)(0.01)

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.